These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 34739624
1. Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography. Podrug K, Trkulja V, Zelenika M, Bokun T, Madir A, Kanizaj TF, O'Beirne J, Grgurevic I. Dig Dis Sci; 2022 Jul; 67(7):3327-3332. PubMed ID: 34739624 [Abstract] [Full Text] [Related]
2. Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography. Grgurevic I, Madir A, Trkulja V, Bozin T, Aralica G, Podrug K, Mikolaševic I, Tsochatzis E, O'Beirne J, Pinzani M. Eur J Clin Invest; 2022 Jun; 52(6):e13750. PubMed ID: 35040495 [Abstract] [Full Text] [Related]
3. Non-invasive tests for clinically significant portal hypertension after HCV cure. Semmler G, Lens S, Meyer EL, Baiges A, Alvardo-Tapias E, Llop E, Tellez L, Schwabl P, Mauro E, Escudé L, Díez C, Ibañez-Samaniego L, Puente Á, Fortea JI, Abadía M, Zanetto A, Conthe A, Hernandez-Évole H, Luzko Scheid IS, Jia J, Yoshiji H, Francque SM, Tsochatzis EA, Russo FP, Crespo G, Forns X, Bañares R, Villanueva C, Hernández-Gea V, Reiberger T, Bosch J, García Pagán JC, Mandorfer M, A study by the Baveno Cooperation: an EASL consortium. J Hepatol; 2022 Dec; 77(6):1573-1585. PubMed ID: 36063968 [Abstract] [Full Text] [Related]
4. Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease. Jindal A, Agarwal S, Sharma S, Kumar M, Saraya A, Sarin SK. Dig Dis Sci; 2023 May; 68(5):2149-2157. PubMed ID: 36562888 [Abstract] [Full Text] [Related]
5. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. Pons M, Augustin S, Scheiner B, Guillaume M, Rosselli M, Rodrigues SG, Stefanescu H, Ma MM, Mandorfer M, Mergeay-Fabre M, Procopet B, Schwabl P, Ferlitsch A, Semmler G, Berzigotti A, Tsochatzis E, Bureau C, Reiberger T, Bosch J, Abraldes JG, Genescà J. Am J Gastroenterol; 2021 Apr; 116(4):723-732. PubMed ID: 33982942 [Abstract] [Full Text] [Related]
6. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta. Jachs M, Sandmann L, Hartl L, Tergast T, Schwarz M, Bauer DJM, Balcar L, Ehrenbauer A, Hofer BS, Cornberg M, Lenzen H, Deterding K, Trauner M, Mandorfer M, Wedemeyer H, Reiberger T, Maasoumy B. J Hepatol; 2024 Aug; 81(2):248-257. PubMed ID: 38479612 [Abstract] [Full Text] [Related]
7. Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography. He R, Liu C, Grgurevic I, Guo Y, Xu H, Liu J, Liu Y, Wang X, Shi H, Madir A, Podrug K, Zhu Y, Hua Y, Wang K, Wen J, Su M, Zhang Q, Li J, Qi X. Hepatol Int; 2024 Jun; 18(3):1020-1028. PubMed ID: 38740698 [Abstract] [Full Text] [Related]
8. Diagnostic accuracy of transient elastography in diagnosing clinically significant portal hypertension in patients with chronic liver disease: a systematic review and meta-analysis. Kumar A, Maruyama H, Arora A, Sharma P, Anikhindi SA, Bansal N, Kumar M, Ranjan P, Sachdeva M, Khare S. J Med Ultrason (2001); 2022 Jul; 49(3):333-346. PubMed ID: 35876975 [Abstract] [Full Text] [Related]
10. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data. Hong WK, Kim MY, Baik SK, Shin SY, Kim JM, Kang YS, Lim YL, Kim YJ, Cho YZ, Hwang HW, Lee JH, Chae MH, Kim HA, Kang HW, Kwon SO. Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641 [Abstract] [Full Text] [Related]
17. Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study. Jachs M, Odriozola A, Turon F, Moga L, Téllez L, Fischer P, Saltini D, Kwanten WJ, Grasso M, Llop E, Mendoza YP, Armandi A, Thalhammer J, Pardo C, Colecchia A, Ravaioli F, Maasoumy B, Laleman W, Presa J, Schattenberg JM, Berzigotti A, Calleja JL, Calvaruso V, Francque S, Schepis F, Procopet B, Albillos A, Rautou PE, García-Pagán JC, Puente Á, Fortea JI, Reiberger T, Mandorfer M, SSM-100Hz/ACLD Study Group, Baveno Cooperation. Lancet Gastroenterol Hepatol; 2024 Dec 01; 9(12):1111-1120. PubMed ID: 39326431 [Abstract] [Full Text] [Related]
18. THE ROLE OF ELASTOGRAPHY IN CLINICALLY SIGNIFICANT PORTAL HYPERTENSION. Mattos AA, Mattos AZ, Sartori GDP, Both GT, Tovo CV. Arq Gastroenterol; 2023 Dec 01; 60(4):525-535. PubMed ID: 38018555 [Abstract] [Full Text] [Related]
19. A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. Dajti E, Ravaioli F, Marasco G, Alemanni LV, Colecchia L, Ferrarese A, Cusumano C, Gemini S, Vestito A, Renzulli M, Golfieri R, Festi D, Colecchia A. Am J Gastroenterol; 2022 Nov 01; 117(11):1825-1833. PubMed ID: 35973171 [Abstract] [Full Text] [Related]